SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-053942
Filing Date
2021-11-03
Accepted
2021-11-03 16:06:16
Documents
72
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 GTHX-Q3-2021 10-Q gthx-10q_20210930.htm   iXBRL 10-Q 2131032
2 EX-10.1 gthx-ex101_163.htm EX-10.1 156214
3 EX-10.2 gthx-ex102_164.htm EX-10.2 415909
4 EX-31.1 gthx-ex311_10.htm EX-31.1 18144
5 EX-31.2 gthx-ex312_7.htm EX-31.2 17875
6 EX-32.1 gthx-ex321_9.htm EX-32.1 7293
7 EX-32.2 gthx-ex322_6.htm EX-32.2 7289
  Complete submission text file 0001564590-21-053942.txt   8098438

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA gthx-20210930.xsd EX-101.SCH 50804
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE gthx-20210930_cal.xml EX-101.CAL 40858
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE gthx-20210930_def.xml EX-101.DEF 165226
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE gthx-20210930_lab.xml EX-101.LAB 400925
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE gthx-20210930_pre.xml EX-101.PRE 304144
13 EXTRACTED XBRL INSTANCE DOCUMENT gthx-10q_20210930_htm.xml XML 1314905
Mailing Address 700 PARK OFFICES DRIVE SUITE 200 RESEARCH TRIANGLE PARK NC 27709
Business Address 700 PARK OFFICES DRIVE SUITE 200 RESEARCH TRIANGLE PARK NC 27709 919-213-9835
G1 Therapeutics, Inc. (Filer) CIK: 0001560241 (see all company filings)

IRS No.: 263648180 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38096 | Film No.: 211375348
SIC: 2834 Pharmaceutical Preparations